Soframycin (2016-01-29)
· Published by Health Canada · Official notice
Alert type: Drug Recall
Category: Drugs
Issue: Product Safety
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type III
| Lot or serial number | Brand name | Companies | Dosage form | DIN, NPN, DIN-HIM | Strength |
|---|
| F0622 | Soframycin | - Recalling Firm
- ERFA Canada 2012 Inc.
- 8250 Decarie, Suite 110
- Montreal
- H4P 2P5
- Quebec
- CANADA
- Marketing Authorization Holder
- ERFA Canada 2012 Inc.
- 8250 Decarie, Suite 110
- Montreal
- H4P 2P5
- Quebec
- CANADA
| Nasal spray | DIN 02224860 | Framycetin 12.5 mg/mL, |
Affected Products
Soframycin
Out of specification result for potency during shelf life testing